The big news this week of course was the announced merger between Aphria and Tilray. Aphria will own over 60% of the combined entity and Irwin Simon, Aphria’s CEO will take on the same role at the new company. However, it will be known as Tilray and use the Tilray symbol.
Mind Medicine (MindMed) Inc. (NEO: MMED) (OTCQB: MMEDF) raised C$80 million in an upsized bought deal. the company said the net proceeds will be used for investment in Project Lucy, Albert (the company’s digital medicine division), additional microdosing research and development, Project Layla (18-MC) as well as general working capital. The original raise was planned for $50 million.